Terbutaline
Terbutaline market is segmented by region (country), players, by Type and by Application. Players ... Read More
Global and United States Dobutamine Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Dobutamine Product Introduction
1.2 Global Dobutamine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Dobutamine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Dobutamine Sales in Volume for the Year 2017-2028
1.3 United States Dobutamine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Dobutamine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Dobutamine Sales in Volume for the Year 2017-2028
1.4 Dobutamine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Dobutamine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Dobutamine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Dobutamine Market Dynamics
1.5.1 Dobutamine Industry Trends
1.5.2 Dobutamine Market Drivers
1.5.3 Dobutamine Market Challenges
1.5.4 Dobutamine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Dobutamine Market Segment by Type
2.1.1 Injection 200mg
2.1.2 Injection 250mg
2.2 Global Dobutamine Market Size by Type
2.2.1 Global Dobutamine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Dobutamine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Dobutamine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Dobutamine Market Size by Type
2.3.1 United States Dobutamine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Dobutamine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Dobutamine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Dobutamine Market Segment by Application
3.1.1 Chronic Heart Failure
3.1.2 Myocardial Infarction
3.1.3 Postoperative Hypotension
3.1.4 Others
3.2 Global Dobutamine Market Size by Application
3.2.1 Global Dobutamine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Dobutamine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Dobutamine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Dobutamine Market Size by Application
3.3.1 United States Dobutamine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Dobutamine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Dobutamine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Dobutamine Competitor Landscape by Company
4.1 Global Dobutamine Market Size by Company
4.1.1 Top Global Dobutamine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Dobutamine Revenue by Manufacturer (2017-2022)
4.1.3 Global Dobutamine Sales by Manufacturer (2017-2022)
4.1.4 Global Dobutamine Price by Manufacturer (2017-2022)
4.2 Global Dobutamine Concentration Ratio (CR)
4.2.1 Dobutamine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dobutamine in 2021
4.2.3 Global Dobutamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Dobutamine Manufacturing Base Distribution, Product Type
4.3.1 Global Dobutamine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Dobutamine Product Type
4.3.3 Date of International Manufacturers Enter into Dobutamine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Dobutamine Market Size by Company
4.5.1 Top Dobutamine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Dobutamine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Dobutamine Sales by Players (2020, 2021 & 2022)
5 Global Dobutamine Market Size by Region
5.1 Global Dobutamine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Dobutamine Market Size in Volume by Region (2017-2028)
5.2.1 Global Dobutamine Sales in Volume by Region: 2017-2022
5.2.2 Global Dobutamine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Dobutamine Market Size in Value by Region (2017-2028)
5.3.1 Global Dobutamine Sales in Value by Region: 2017-2022
5.3.2 Global Dobutamine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Dobutamine Market Size YoY Growth 2017-2028
6.1.2 North America Dobutamine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Dobutamine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Dobutamine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Dobutamine Market Size YoY Growth 2017-2028
6.3.2 Europe Dobutamine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Dobutamine Market Size YoY Growth 2017-2028
6.4.2 Latin America Dobutamine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Dobutamine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Dobutamine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Ivax Pharmaceuticals
7.1.1 Ivax Pharmaceuticals Corporation Information
7.1.2 Ivax Pharmaceuticals Description and Business Overview
7.1.3 Ivax Pharmaceuticals Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Ivax Pharmaceuticals Dobutamine Products Offered
7.1.5 Ivax Pharmaceuticals Recent Development
7.2 Physicians Total Care
7.2.1 Physicians Total Care Corporation Information
7.2.2 Physicians Total Care Description and Business Overview
7.2.3 Physicians Total Care Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Physicians Total Care Dobutamine Products Offered
7.2.5 Physicians Total Care Recent Development
7.3 Baxter Healthcare
7.3.1 Baxter Healthcare Corporation Information
7.3.2 Baxter Healthcare Description and Business Overview
7.3.3 Baxter Healthcare Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Baxter Healthcare Dobutamine Products Offered
7.3.5 Baxter Healthcare Recent Development
7.4 Sanofi
7.4.1 Sanofi Corporation Information
7.4.2 Sanofi Description and Business Overview
7.4.3 Sanofi Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi Dobutamine Products Offered
7.4.5 Sanofi Recent Development
7.5 Teva Canada
7.5.1 Teva Canada Corporation Information
7.5.2 Teva Canada Description and Business Overview
7.5.3 Teva Canada Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Teva Canada Dobutamine Products Offered
7.5.5 Teva Canada Recent Development
7.6 Pfizer
7.6.1 Pfizer Corporation Information
7.6.2 Pfizer Description and Business Overview
7.6.3 Pfizer Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Pfizer Dobutamine Products Offered
7.6.5 Pfizer Recent Development
7.7 Bedford Laboratories
7.7.1 Bedford Laboratories Corporation Information
7.7.2 Bedford Laboratories Description and Business Overview
7.7.3 Bedford Laboratories Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Bedford Laboratories Dobutamine Products Offered
7.7.5 Bedford Laboratories Recent Development
7.8 Novartis
7.8.1 Novartis Corporation Information
7.8.2 Novartis Description and Business Overview
7.8.3 Novartis Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Novartis Dobutamine Products Offered
7.8.5 Novartis Recent Development
7.9 Sterimax
7.9.1 Sterimax Corporation Information
7.9.2 Sterimax Description and Business Overview
7.9.3 Sterimax Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Sterimax Dobutamine Products Offered
7.9.5 Sterimax Recent Development
7.10 Teligent
7.10.1 Teligent Corporation Information
7.10.2 Teligent Description and Business Overview
7.10.3 Teligent Dobutamine Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Teligent Dobutamine Products Offered
7.10.5 Teligent Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Dobutamine Industry Chain Analysis
8.2 Dobutamine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Dobutamine Distributors
8.3 Dobutamine Production Mode & Process
8.4 Dobutamine Sales and Marketing
8.4.1 Dobutamine Sales Channels
8.4.2 Dobutamine Distributors
8.5 Dobutamine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Dobutamine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Dobutamine Market Trends
Table 3. Dobutamine Market Drivers
Table 4. Dobutamine Market Challenges
Table 5. Dobutamine Market Restraints
Table 6. Global Dobutamine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Dobutamine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Dobutamine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Dobutamine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Dobutamine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Dobutamine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Dobutamine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Dobutamine Sales by Manufacturer, (MT), 2017-2022
Table 14. Global Dobutamine Sales Share by Manufacturer, 2017-2022
Table 15. Global Dobutamine Price by Manufacturer (2017-2022) & (USD/Kg)
Table 16. Global Dobutamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Dobutamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dobutamine as of 2021)
Table 18. Top Players of Dobutamine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Dobutamine Product Type
Table 20. Date of International Manufacturers Enter into Dobutamine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Dobutamine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Dobutamine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Dobutamine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Dobutamine Sales by Players, (MT), 2020, 2021 & 2022
Table 26. United States Dobutamine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Dobutamine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Dobutamine Sales in Volume by Region (2017-2022) & (MT)
Table 29. Global Dobutamine Sales in Volume Forecast by Region (2023-2028) & (MT)
Table 30. Global Dobutamine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Dobutamine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Dobutamine Sales in Volume by Country (2017-2028) & (MT)
Table 33. North America Dobutamine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Dobutamine Sales in Volume by Region (2017-2028) & (MT)
Table 35. Asia Pacific Dobutamine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Dobutamine Sales in Volume by Country (2017-2028) & (MT)
Table 37. Europe Dobutamine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Dobutamine Sales in Volume by Country (2017-2028) & (MT)
Table 39. Latin Americaa Dobutamine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Dobutamine Sales in Volume by Country (2017-2028) & (MT)
Table 41. Middle East and Africa Dobutamine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Ivax Pharmaceuticals Corporation Information
Table 43. Ivax Pharmaceuticals Description and Business Overview
Table 44. Ivax Pharmaceuticals Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 45. Ivax Pharmaceuticals Dobutamine Product
Table 46. Ivax Pharmaceuticals Recent Development
Table 47. Physicians Total Care Corporation Information
Table 48. Physicians Total Care Description and Business Overview
Table 49. Physicians Total Care Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 50. Physicians Total Care Product
Table 51. Physicians Total Care Recent Development
Table 52. Baxter Healthcare Corporation Information
Table 53. Baxter Healthcare Description and Business Overview
Table 54. Baxter Healthcare Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 55. Baxter Healthcare Product
Table 56. Baxter Healthcare Recent Development
Table 57. Sanofi Corporation Information
Table 58. Sanofi Description and Business Overview
Table 59. Sanofi Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 60. Sanofi Product
Table 61. Sanofi Recent Development
Table 62. Teva Canada Corporation Information
Table 63. Teva Canada Description and Business Overview
Table 64. Teva Canada Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 65. Teva Canada Product
Table 66. Teva Canada Recent Development
Table 67. Pfizer Corporation Information
Table 68. Pfizer Description and Business Overview
Table 69. Pfizer Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 70. Pfizer Product
Table 71. Pfizer Recent Development
Table 72. Bedford Laboratories Corporation Information
Table 73. Bedford Laboratories Description and Business Overview
Table 74. Bedford Laboratories Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 75. Bedford Laboratories Product
Table 76. Bedford Laboratories Recent Development
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 80. Novartis Product
Table 81. Novartis Recent Development
Table 82. Sterimax Corporation Information
Table 83. Sterimax Description and Business Overview
Table 84. Sterimax Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 85. Sterimax Product
Table 86. Sterimax Recent Development
Table 87. Teligent Corporation Information
Table 88. Teligent Description and Business Overview
Table 89. Teligent Dobutamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 90. Teligent Product
Table 91. Teligent Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Dobutamine Customers List
Table 95. Dobutamine Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Dobutamine Product Picture
Figure 2. Global Dobutamine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Dobutamine Market Size 2017-2028 (US$ Million)
Figure 4. Global Dobutamine Sales 2017-2028 (MT)
Figure 5. United States Dobutamine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Dobutamine Market Size 2017-2028 (US$ Million)
Figure 7. United States Dobutamine Sales 2017-2028 (MT)
Figure 8. United States Dobutamine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Dobutamine Market Share in Global, in Volume (MT) 2017-2028
Figure 10. Dobutamine Report Years Considered
Figure 11. Product Picture of Injection 200mg
Figure 12. Product Picture of Injection 250mg
Figure 13. Global Dobutamine Market Share by Type in 2022 & 2028
Figure 14. Global Dobutamine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Dobutamine Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Dobutamine Sales by Type (2017-2028) & (MT)
Figure 17. Global Dobutamine Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Dobutamine Price by Type (2017-2028) & (USD/Kg)
Figure 19. United States Dobutamine Market Share by Type in 2022 & 2028
Figure 20. United States Dobutamine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Dobutamine Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Dobutamine Sales by Type (2017-2028) & (MT)
Figure 23. United States Dobutamine Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Dobutamine Price by Type (2017-2028) & (USD/Kg)
Figure 25. Product Picture of Chronic Heart Failure
Figure 26. Product Picture of Myocardial Infarction
Figure 27. Product Picture of Postoperative Hypotension
Figure 28. Product Picture of Others
Figure 29. Global Dobutamine Market Share by Application in 2022 & 2028
Figure 30. Global Dobutamine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Dobutamine Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Dobutamine Sales by Application (2017-2028) & (MT)
Figure 33. Global Dobutamine Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Dobutamine Price by Application (2017-2028) & (USD/Kg)
Figure 35. United States Dobutamine Market Share by Application in 2022 & 2028
Figure 36. United States Dobutamine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Dobutamine Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Dobutamine Sales by Application (2017-2028) & (MT)
Figure 39. United States Dobutamine Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Dobutamine Price by Application (2017-2028) & (USD/Kg)
Figure 41. North America Dobutamine Sales in Volume Growth Rate 2017-2028 (MT)
Figure 42. North America Dobutamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Dobutamine Sales in Volume Growth Rate 2017-2028 (MT)
Figure 46. Europe Dobutamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Dobutamine Sales in Volume Growth Rate 2017-2028 (MT)
Figure 53. Asia-Pacific Dobutamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Dobutamine Sales in Volume Growth Rate 2017-2028 (MT)
Figure 65. Latin America Dobutamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Dobutamine Sales in Volume Growth Rate 2017-2028 (MT)
Figure 70. Middle East & Africa Dobutamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Dobutamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Dobutamine Value Chain
Figure 75. Dobutamine Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ivax Pharmaceuticals Physicians Total Care Baxter Healthcare Sanofi Teva Canada Pfizer Bedford Laboratories Novartis Sterimax Teligent